NEW YORK (GenomeWeb) – Exact Science said in a document filed yesterday with the US Securities and Exchange Commission that it has raised $671.3 million in a previously announced senior notes offering.

Exact entered into an agreement with underwriter Merrill Lynch to sell $600 million in 1 percent convertible senior notes due 2025, and granted the underwriter an option to purchase up to an additional $90 million in notes, which it exercised in full.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.